Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cystoid macular edema in uveitis].

S R Thurau1

  • 1Augenklinik, Ludwig-Maximilians-Universität, München.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|March 5, 2005
PubMed
Summary

Cystoid macular edema (CME) significantly impairs vision in uveitis patients. Early diagnosis and treatment are crucial for preserving visual acuity, even before symptoms appear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recurrent uveitis of unknown origin in childhood].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2010
Same author

[Topical and systemic corticosteroid therapy for uveitis in childhood].

Klinische Monatsblatter fur Augenheilkunde·2007
Same author

[Unilateral visual deterioration due to macular tumour of unclear origin. 32-year old female patient with sudden low vision in the right eye].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2003
Same author

A tourist with dengue fever and visual loss.

Lancet (London, England)·2002
Same author

Immunopathology of recurrent uveitis in spontaneously diseased horses.

Experimental eye research·2002
Same author

Immune responses to retinal autoantigens and peptides in equine recurrent uveitis.

Investigative ophthalmology & visual science·2001

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Cystoid macular edema (CME) is a primary cause of vision loss in uveitis.
  • Intraocular inflammation compromises the blood-retina barrier, inducing retinal edema.

Purpose of the Study:

  • To emphasize the importance of early diagnosis and treatment of CME in uveitis patients.
  • To outline current therapeutic strategies for managing CME and uveitis.

Main Methods:

  • Review of current therapeutic approaches for uveitis-associated CME.
  • Discussion of the role of anti-inflammatory, immunosuppressive, and fluid-resorbing agents.

Main Results:

  • Corticosteroids and NSAIDs aid in restoring the blood-retina barrier.
  • Systemic carbonic anhydrase inhibitors assist in extracellular fluid resorption.
  • Despite treatment, visual acuity loss remains common.

Conclusions:

  • Aggressive anti-inflammatory and immunosuppressive therapy is the cornerstone for managing uveitis-associated CME.
  • Prompt diagnosis and intervention, even in asymptomatic stages, are essential for optimal visual outcomes.

Related Experiment Videos